Jane Street’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-65,000
Closed -$1.75M 10453
2022
Q4
$1.75M Sell
65,000
-4,300
-6% -$113K ﹤0.01% 4054
2022
Q3
$1.25M Buy
69,300
+32,500
+88% +$519K ﹤0.01% 5024
2022
Q2
$457K Sell
36,800
-20,100
-35% -$222K ﹤0.01% 6904
2022
Q1
$758K Sell
56,900
-4,900
-8% -$65.7K ﹤0.01% 6702
2021
Q4
$962K Buy
61,800
+26,800
+77% +$512K ﹤0.01% 5982
2021
Q3
$785K Sell
35,000
-79,800
-70% -$1.75M ﹤0.01% 6406
2021
Q2
$2.61M Buy
114,800
+45,300
+65% +$953K ﹤0.01% 3815
2021
Q1
$1.43M Buy
69,500
+17,600
+34% +$401K ﹤0.01% 4713
2020
Q4
$1.43M Sell
51,900
-71,600
-58% -$1.39M ﹤0.01% 4074
2020
Q3
$1.74M Buy
123,500
+100,700
+442% +$1.87M ﹤0.01% 3261
2020
Q2
$470K Buy
+22,800
New +$310K ﹤0.01% 5172

Other funds holding MYOV

Jane Street's MYOV Position: Q1 2023 in Review

Jane Street sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 18,064 shares — an estimated $487K sold.

Jane Street first reported a position in MYOV in Q4 2019 and held it in 11 quarters. The position peaked at $1.53M in Q2 2021. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Jane Street reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 18,064 Myovant Sciences Ltd. shares in Q1 2023, an estimated $487K.
  • Jane Street first reported a position in Myovant Sciences Ltd. in Q4 2019 and held it in 11 quarters.
  • Jane Street's Myovant Sciences Ltd. position peaked at $1.53M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.